111 related articles for article (PubMed ID: 8388367)
1. Comparative conformational analysis and in vitro pharmacological evaluation of three cyclic hexapeptide NK-2 antagonists.
Wollborn U; Brunne RM; Harting J; Hölzemann G; Leibfritz D
Int J Pept Protein Res; 1993 Apr; 41(4):376-84. PubMed ID: 8388367
[TBL] [Abstract][Full Text] [Related]
2. Solution conformation of a cyclic neurokinin antagonist: a NMR and molecular dynamics study.
Zhang M; Quinn TP; Wong TC
Biopolymers; 1994 Sep; 34(9):1165-73. PubMed ID: 7948730
[TBL] [Abstract][Full Text] [Related]
3. Influence of the replacement of amino acid by its D-enantiomer in the sequence of substance P. 2. Conformational analysis by NMR and energy calculations.
Convert O; Duplaa H; Lavielle S; Chassaing G
Neuropeptides; 1991 Aug; 19(4):259-70. PubMed ID: 1717877
[TBL] [Abstract][Full Text] [Related]
4. Conformational study of cyclo[Gln-Trp-Phe-Gly-Leu-Met] as NK-2 antagonist by NMR and molecular dynamics.
Siahaan TJ; Lutz K
J Pharm Biomed Anal; 1994 Jan; 12(1):65-71. PubMed ID: 8161607
[TBL] [Abstract][Full Text] [Related]
5. Cyclic peptides as selective tachykinin antagonists.
Williams BJ; Curtis NR; McKnight AT; Maguire JJ; Young SC; Veber DF; Baker R
J Med Chem; 1993 Jan; 36(1):2-10. PubMed ID: 7678430
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological specificity of novel, synthetic, cyclic peptides as antagonists at tachykinin receptors.
McKnight AT; Maguire JJ; Elliott NJ; Fletcher AE; Foster AC; Tridgett R; Williams BJ; Longmore J; Iversen LL
Br J Pharmacol; 1991 Oct; 104(2):355-60. PubMed ID: 1665732
[TBL] [Abstract][Full Text] [Related]
7. Importance of the leucine side-chain to the spasmogenic activity and binding of substance P analogues.
Lavielle S; Chassaing G; Brunissen A; Rodriguez M; Martinez J; Convert O; Carruette A; Garret C; Petitet F; Saffroy M
Int J Pept Protein Res; 1993 Sep; 42(3):270-7. PubMed ID: 7693605
[TBL] [Abstract][Full Text] [Related]
8. Further evidence for the existence of NK2 tachykinin receptor subtypes.
Patacchini R; Astolfi M; Quartara L; Rovero P; Giachetti A; Maggi CA
Br J Pharmacol; 1991 Sep; 104(1):91-6. PubMed ID: 1664768
[TBL] [Abstract][Full Text] [Related]
9. Combined use of molecular dynamics simulations and NMR to explore peptide bond isomerization and multiple intramolecular hydrogen-bonding possibilities in a cyclic pentapeptide, cyclo(Gly-Pro-D-Phe-Gly-Val).
Liu ZP; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1727-39. PubMed ID: 1472655
[TBL] [Abstract][Full Text] [Related]
10. Tachykinin antagonists: substitutions in positions 5 and 6 with amino acids from the primary sequence of substance P homologues.
Mathison R; Escher E; Huggel H; Mizrahi J; Regoli D
Eur J Pharmacol; 1985 Aug; 114(2):147-55. PubMed ID: 2412854
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and solution structure of an S-glycosylated cyclic hexapeptide. Evidence for conformational change induced by glycosylation.
Gerz M; Matter H; Kessler H
Int J Pept Protein Res; 1994 Mar; 43(3):248-57. PubMed ID: 8005747
[TBL] [Abstract][Full Text] [Related]
12. Influence of serine in position i on conformation and dynamics of reverse turns.
Matter H; Gemmecker G; Kessler H
Int J Pept Protein Res; 1995 May; 45(5):430-40. PubMed ID: 7591482
[TBL] [Abstract][Full Text] [Related]
13. Cyclic hexapeptide NK-2 antagonists.
Hölzemann G; Löw A; Harting J; Greiner HE
Int J Pept Protein Res; 1994 Aug; 44(2):105-11. PubMed ID: 7527014
[TBL] [Abstract][Full Text] [Related]
14. Conformation of CD4-derived cyclic hexapeptides by NMR and molecular dynamics.
Ma S; McGregor MJ; Cohen FE; Pallai PV
Biopolymers; 1994 Aug; 34(8):987-1000. PubMed ID: 8075393
[TBL] [Abstract][Full Text] [Related]
15. Spantide II, an effective tachykinin antagonist having high potency and negligible neurotoxicity.
Folkers K; Feng DM; Asano N; Håkanson R; Weisenfeld-Hallin Z; Leander S
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4833-5. PubMed ID: 1693780
[TBL] [Abstract][Full Text] [Related]
16. Mimicry of beta II'-turns of proteins in cyclic pentapeptides with one and without D-amino acids.
Weisshoff H; Präsang C; Henklein P; Frömmel C; Zschunke A; Mügge C
Eur J Biochem; 1999 Feb; 259(3):776-88. PubMed ID: 10092864
[TBL] [Abstract][Full Text] [Related]
17. A 1H-NMR study of the solution conformation of cyclo(GRGDSPA): conformational effects on the physiological activity.
Mizutani R; Shimada I; Ueno Y; Yoda M; Kumagai H; Arata Y
Biochem Biophys Res Commun; 1992 Jan; 182(2):966-73. PubMed ID: 1734894
[TBL] [Abstract][Full Text] [Related]
18. N-terminal truncated analogs of men 10376 as tachykinin NK-2 receptor antagonists.
Quartara L; Patacchini R; Giuliani S; Renzetti AR; Rovero P; Maggi CA
Life Sci; 1992; 51(25):1929-36. PubMed ID: 1333561
[TBL] [Abstract][Full Text] [Related]
19. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
Stroup AN; Rockwell AL; Gierasch LM
Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
[TBL] [Abstract][Full Text] [Related]
20. Unusual thionation of a cyclic hexapeptide. Conformational changes and dynamics.
Kessler H; Geyer A; Matter H; Köck M
Int J Pept Protein Res; 1992 Jul; 40(1):25-40. PubMed ID: 1428538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
